News

Medpage Today on MSN1mon
First Generics for Low-Dose Rivaroxaban Get FDA Approval
and to reduce the risk of major thrombotic vascular events in adults with peripheral artery disease (PAD), including patients ...
The Nassau Guardian2d
Amputation prevention
April is amputation prevention awareness month. Amputation rates are increasing in The Bahamas, the Caribbean and worldwide. In the United States, 160,000 people with diabetes undergo lower extremity ...
MyChesCo on MSN1mon
FDA Approves Lifesaving Stroke Drug, Xarelto Generics, and Issues Urgent Testosterone Warnings
It is also indicated for use following lower extremity revascularization procedures due to symptomatic PAD. Anticoagulants, ...
The Trentonian3y
Late-Breaking Data at ACC.21 Show XARELTO(R)…
CLICK TO TWEET: Late-breaking data at #ACC21 offer insights on long-term prevention of future thrombotic events in patients with #PAD after lower-extremity revascularization. Full @JanssenUS press ...